Diclofenac Sodium
Average across 59 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Bryant Ranch Prepack | repackager | 67 | SUPPLYING |
| A-S Medication Solutions | repackager | 51 | SUPPLYING |
| Proficient Rx LP | repackager | 38 | SUPPLYING |
| Preferred Pharmaceuticals Inc. | repackager | 21 | SUPPLYING |
| NuCare Pharmaceuticals,Inc. | repackager | 20 | SUPPLYING |
| Golden State Medical Supply, Inc. | repackager | 19 | SUPPLYING |
| Carlsbad Technology, Inc. | unknown | 17 | SUPPLYING |
| Advagen Pharma Ltd | unknown | 15 | SUPPLYING |
| Asclemed USA, Inc. | repackager | 14 | SUPPLYING |
| PD-Rx Pharmaceuticals, Inc. | repackager | 12 | SUPPLYING |
| Redpharm Drug | repackager | 10 | SUPPLYING |
| Rising Pharma Holdings, Inc. | generic | 9 | SUPPLYING |
| Umedica Laboratories USA Inc. | unknown | 9 | SUPPLYING |
| BluePoint Laboratories | relabeler | 8 | SUPPLYING |
| Aurobindo Pharma Limited | generic | 7 | SUPPLYING |
+ 17 more labelers
Shortages, recalls, and registration changes attached to this drug concept.
Diclofenac Sodium Tablet, Delayed Release — reported in shortage by Teva Pharmaceuticals USA, Inc.. Therapeutic category: Musculoskeletal, Rheumatology.
Diclofenac Sodium Tablet, Delayed Release — reported in shortage by Teva Pharmaceuticals USA, Inc.. Therapeutic category: Musculoskeletal, Rheumatology.
